Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|December 28, 2014
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxelNicholas Coupe, Pippa Corrie, Mirela Hategan, et al.
British Journal of Haematology|April 2, 2005
Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trialAnindita Roy, Mike Bradburn, Anthony V Moorman, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2023
An Overview of Current Statistical Methods for Implementing Quality Tolerance LimitsRakhi Kilaru, Sonia Amodio, Yasha Li, et al.
JAMA Network Open|April 2, 2026
Barriers and Facilitators of Platform TrialsStuart McLennan, Alexandra Griessbach, Sharon Love, et al.
Lancet (London, England)|December 7, 2010
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trialCatriona Parker, Rachel Waters, Carly Leighton, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2019
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinomaAnne Thomas, Pradeep S Virdee, Martin Eatock, et al.
The Lancet. Oncology|September 24, 2016
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trialRachel S Kerr, Sharon Love, Eva Segelov, et al.
Gastroenterology|May 18, 2025
Cost-Effectiveness of Regular Surveillance Versus Endoscopy at Need for Patients With Barrett's Esophagus: Economic Evaluation Alongside the Barrett's Oesophagus Surveillance Study (BOSS) Randomized Controlled TrialManuela Deidda, Oliver Old, Janusz Jankowski, et al.
British Journal of Cancer|October 7, 2016
RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learntAvinash Gupta, Corran Roberts, Finn Tysoe, et al.
Gastroenterology|April 3, 2025
Barrett's Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled TrialOliver Old, Janusz Jankowski, Stephen Attwood, et al.
Pageof 4